Purchase Order HHSN302201700038P

<p>The National Human Genome Research Institute issued a purchase order to the Trustees of the University of Pennsylvania on June 28, 2016, with a ceiling value of $4,129.20 and firm fixed pricing. Place of performance is Bethesda, Maryland. The order was completed by December 21, 2020. No set-aside designation was used.</p>

<p>The National Human Genome Research Institute issued a purchase order to Medical Neurogenetics, LLC on February 6, 2018, for clinical genetic testing with a ceiling value of $249,481.00. Work is performed in Bethesda, Maryland. The order was completed by November 2, 2023. Pricing is firm fixed price with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a purchase order to Emory University valued at $16,083.75, awarded February 12, 2016, with completion by February 14, 2017. Performance occurs in Thera 847 00, Greece. The order is firm fixed price with no set-aside designation.</p>

<p>The National Human Genome Research Institute issued a purchase order to Fox Chase Cancer Center on December 2, 2016, for sequencing services valued at $3,840.00. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure and is scheduled for completion by December 31, 2016.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Eurofins Genomics LLC for $2,890.53 on August 29, 2016. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing and expired on September 30, 2016. No set-aside was used.</p>

<p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Bio Basic Canada Inc. for $1,834.68 on February 26, 2016. Performance is located in Bethesda, Maryland. The order carries a firm fixed price and no set-aside designation. Ultimate completion was scheduled for December 29, 2020.</p>

<p>The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.</p>